Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi June Kim

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Haematologica|February 6, 2025
Emerging technologies of single-cell multi-omicsYi June Kim, Koichi Takahashi
Biorxiv : the Preprint Server for Biology|April 17, 2023
Targeting MCL1-driven anti-apoptotic pathways to overcome hypomethylating agent resistance in <i>RAS</i> -mutated chronic myelomonocytic leukemiaGuillermo Montalban-Bravo, Feiyang Ma, Natthakan Thongon, et al.
Cell Reports. Medicine|May 23, 2024
Targeting MCL1-driven anti-apoptotic pathways overcomes blast progression after hypomethylating agent failure in chronic myelomonocytic leukemiaGuillermo Montalban-Bravo, Natthakan Thongon, Juan Jose Rodriguez-Sevilla, et al.
Blood Cancer Discovery|April 27, 2023
A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1-Mutated Myeloid MalignanciesCurtis A Lachowiez, Sanam Loghavi, Zhihong Zeng, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Haematologica|February 6, 2025
Emerging technologies of single-cell multi-omicsYi June Kim, Koichi Takahashi
Biorxiv : the Preprint Server for Biology|April 17, 2023
Targeting MCL1-driven anti-apoptotic pathways to overcome hypomethylating agent resistance in <i>RAS</i> -mutated chronic myelomonocytic leukemiaGuillermo Montalban-Bravo, Feiyang Ma, Natthakan Thongon, et al.
Cell Reports. Medicine|May 23, 2024
Targeting MCL1-driven anti-apoptotic pathways overcomes blast progression after hypomethylating agent failure in chronic myelomonocytic leukemiaGuillermo Montalban-Bravo, Natthakan Thongon, Juan Jose Rodriguez-Sevilla, et al.
Blood Cancer Discovery|April 27, 2023
A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1-Mutated Myeloid MalignanciesCurtis A Lachowiez, Sanam Loghavi, Zhihong Zeng, et al.
Pageof 1